Engineered skin bacteria induce antitumor T cell responses against melanoma
Open accessPublished version of a preprint
The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
Certain bacterial colonists induce a highly specific T cell response. A hallmark of this encounter is that adaptive immunity develops preemptively, in the absence of an infection. However, the functional properties of colonist-induced T cells are not well defined, limiting our ability to understand anticommensal immunity and harness it therapeutically. We addressed both challenges by engineering the skin bacterium Staphylococcus epidermidis to express tumor antigens anchored to secreted or cell-surface proteins. Upon colonization, engineered S. epidermidis elicits tumor-specific T cells that circulate, infiltrate local and metastatic lesions, and exert cytotoxic activity. Thus, the immune response to a skin colonist can promote cellular immunity at a distal site and can be redirected against a target of therapeutic interest by expressing a target-derived antigen in a commensal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Staphylococcus epidermidis can be genetically manipulated to express tumor antigens and to prevent or treat cancers expressing such antigens, including melanoma.178”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [178]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Car t cell immunotherapy for human cancer
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Research works printed but not linked: 1
- J. G. Swoboda “Wall teichoic acid biosynthesis as a novel antimicrobial target in Staphylococcus aureus ” thesis Harvard University (2009).
Cited by
Items 101–193 of 193
Pierro, F. D., Thacharodi, A., Kumaraswami, M., Suvorov, A. N., Zupet, J., & Zerbinati, N. (2026) · Microbial Cell Factories · doi:10.1186/s12934-026-02997-w · Cited by 12
Bacterial Expression of Promelittin for Safe and Effective Tumor Therapy
Xu, W., Chen, H., Duan, Y., Ge, D., Ren, D., Zhao, S., Liu, Y., Ma, L., & Zhang, C. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c11457 · Cited by 8
Engineering Bacteria for Environmental Release: Regulatory Challenges and Design StrategiesPreprint
Chemla, Y., Sweeney, C. J., Wozniak, C. A., & Voigt, C. A. (2024) · doi:10.22541/au.171933709.97462270/v1 · Cited by 8
Liang, R., Lin, F., Mo, X., Long, J., Tang, W., Luo, T., & Huang, Y. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c09122 · Cited by 7
Shqair, L., Draw, I., Maya, T., Bunick, C. G., Akbarialiabad, H., Schlesinger, T. E., Damiani, G. B., Ghannoum, M. A., & Grada, A. A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111438 · Cited by 7
Fine-tuning immunity against cancer: the emergence of engineered commensal microbiota
He, S., Yang, F., Zuo, J.-P., & Lin, Z. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.05.024 · Cited by 7
Microbiota mechanisms in cancer progression and therapy
Zhang, X., Fam, K. T., Dai, T., & Hang, H. C. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.005 · Cited by 9
Chang, X., Liu, X., Wang, X., Ma, L., Liang, J., & Li, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1545334 · Cited by 9
Jost, S., Cardona, L., Rohrbach, E., Mathis, A., Holliger, C., & Verhulst, N. O. (2023) · Veterinary Dermatology · doi:10.1111/vde.13223 · Cited by 7
The role of the microbiome in skin cancer development and treatment
Fuentes, A. M. (2025) · Current Opinion in Oncology · doi:10.1097/cco.0000000000001120 · Cited by 8
Decker-Farrell, A. R., Sastra, S. A., Harimoto, T., Hasselluhn, M. C., Palermo, C. F., Ballister, E. R., Badgley, M. A., Danino, T., & Olive, K. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.02.592216 · Cited by 7
Repurposing the bacterial surface display technology for drug delivery
Yang, S., Yang, M., Jennings, M., Timek, H., Haley, A. E., Romee, R., & Li, J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115701 · Cited by 10
Unveiling the interplay between microbiota and PD1/PD-L1 axis in tumor immunity and immunotherapy
Lu, Q., Wu, J., Yu, X., Qian, J., & Song, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690374 · Cited by 6
Benjamin, K. N., Goyal, A., Nair, R. V., & Endy, D. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1408796 · Cited by 7
Hamza, M., Wang, S., Liu, Y., Li, K., Zhu, M., & Chen, L. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128156 · Cited by 6
Fu, W., Ling, J., Omer, A. M., Ouyang, X., Mei, L., & Wang, N. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.168014 · Cited by 5
Dynamic remodeling of skin microbiota during healthy homeostatic and wound repair conditions
Ye, H., Wong, A., Chen, X., Sun, W., He, H., Li, X., & Wu, J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1781606 · Cited by 5
Takahashi, H., Fukuda, K., Ito, Y., & Amagai, M. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.05.021 · Cited by 5
Designer bugs as cancer drugs?
Sajjath, S. M., Gola, A., & Fuchs, E. V. (2023) · Science · doi:10.1126/science.adh3884 · Cited by 5
Surface display of two neoantigens on Lactiplantibacillus plantarum
Wiull, K., Holmgren, E., Svensson, S., Eijsink, V. G. H., Grönlund, H., & Mathiesen, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-91180-z · Cited by 5
An inverse relationship between fitness and secretion efficiency in a gram-positive bacterium
Wiull, K., Kjos, M., Eijsink, V. G. H., & Mathiesen, G. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf131 · Cited by 4
Engineering commensal Lachnospiraceae for programmable therapeutic delivery in the mouse gut
Arnold, J. H., McClure, S., Glazier, J., Shakya, S., Jansen, Z., Ahan, R. E., Villegas, D., Chen, T. L., Fuerte-Stone, J., McGann, R., et al. (2026) · Nature Microbiology · doi:10.1101/2025.11.08.687059 · Cited by 5
Deng, M., Sun, Z., Zhang, X., Zhang, Q., Chen, S., Lan, T., Wang, L., Mahdinloo, S., Wang, H., Li, J., et al. (2026) · Materials Today · doi:10.1016/j.mattod.2026.103230 · Cited by 4
Engineering commensal microbes for host health
Brown, E. A., Brevi, A., Zong, D. M., & Zarrinpar, A. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.025 · Cited by 4
Shi, Y., Zhao, W., Ding, Y., Ge, X., & Ju, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1467098 · Cited by 4
Renteria-Flores, F. I., García‐Chagollán, M., & Jave‐Suárez, L. F. (2024) · Vaccines · doi:10.3390/vaccines12090968 · Cited by 7
Wang, X., & Zhu, Z. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1422132 · Cited by 5
Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity
Gribonika, I. (2025) · Immunological Reviews · doi:10.1111/imr.70061 · Cited by 3
Wang, J., Li, H., Gao, M., Xie, Y., Zhu, G., Qian, Y., Lin, J., & Li, C. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202510738 · Cited by 3
Li, Y., Ren, L., Li, H., Xu, Z., Chen, M., Yang, J. J., Wang, Z., Yuan, J., Zhang, S., Wei, S., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202519382 · Cited by 4
Gas plasma-induced bacterial PAMP release promotes skin cancer cell death
Berner, J., Sieben, M., Freund, E., Schulan, P., Miebach, L., & Bekeschus, S. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08283-8 · Cited by 3
Antigen-specific activation of gut immune cells drives autoimmune neuroinflammation
Siewert, L. K., Berve, K., Pössnecker, E., Dyckow, J., Zulji, A., Baumann, R., Muñoz-Blázquez, A., Krishnamoorthy, G., Schreiner, D., Sagan, S. A., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2601430 · Cited by 4
Self-citationBiomimetic materials for medical applications
Zhang, Y., Guo, J., Luo, Q., Zhang, X., Fan, C., Feng, S., Luo, J., Fan, Y., Wei, Q., Li, J., et al. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004036 · Cited by 3
Genomic investigation of innate sensing pathways in the tumor microenvironment
Quinn, G. M., Maggiore, G., & Li, B. (2024) · BMC Cancer · doi:10.1186/s12885-024-12944-w · Cited by 3
Advances in engineered bacteria vaccines for enhancing anti-cancer immunity
Liu, W., Chen, W., Cai, Y., Tang, Y., & Chen, T. (2025) · Microbiome Research Reports · doi:10.20517/mrr.2024.75 · Cited by 3
Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis
Kepp, O., Zitvogel, L., & Kroemer, G. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2212547 · Cited by 3
Disease Dynamics: Insights from Microbiome and Multi-Omics Analysis
Mishra, T., Tiwari, P. B., Rezaei, A. R., Mallik, B., Kanchan, S., & Kesheri, M. (2025) · Springer eBooks · doi:10.1007/978-981-96-7067-3_3 · Cited by 3
Probiotics lead to a new frontier in tumor fighting: tumor vaccines based on probiotics
Ma, T., Liang, Q., Zhou, Z., & Shen, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07426-x · Cited by 3
Ye, F., & Zheng, H. (2025) · Health engineering. · doi:10.26599/he.2025.9460011 · Cited by 2
Shaping the Tumor Microenvironment: Insights from Host–Microbiota Interactions
Lam, K. C., & Goldszmid, R. S. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-1350 · Cited by 2
Conserved CD4+ T cell staphylococcal and streptococcal epitopes enable broad-acting vaccines in mice
Braverman, J., Monk, I. R., Turner, A. M., Braun, A., Zhang, H., Chung, S., Jones, C. M., Zareie, P., Gruta, N. L. L., Rimmer, J., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02265-y · Cited by 2
Harnessing engineered bacteria for revolutionizing cancer immunotherapy
Zhou, K., Cao, L., Luo, H.-Y., Wang, K.-N., Song, Z., & Bu, L. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01664-3 · Cited by 2
Microbiome in Gastrointestinal Tumors: Implications in Oncogenesis and Therapeutic Response
Gómez-Montañez, E., Rojas-Salazar, Y. L., & Rojas-Salazar, J. G. (2026) · Current Oncology Reports · doi:10.1007/s11912-026-01793-4 · Cited by 2
Bacterial engineering for cancer therapy
Chen, N., Yang, Z., & Arpaia, N. (2026) · Nature Cancer · doi:10.1038/s43018-026-01171-w · Cited by 3
Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment
Khan, M., Dong, Y., Ullah, R., Li, M., Huang, Q., Hu, Y., Li, Y., & Luo, Z. Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401076 · Cited by 2
Skin as an autonomous immune organ: Antibody production and host protection
Deng, W., & Li, T. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.027 · Cited by 2
Microbial mechanistic requirements for eliciting a topical and intranasal immune responsePreprint
Bauman, K. D., Lalgudi, P. V., Bousbaine, D., James, A., Chiang, M. L., Nguyen, T. T. D., Swenson, J. M., Tsang, E., Kim, H. J., Ruiz, F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.738787 · Cited by 2
Self-citationThe role of Gram‐positive cocci in cancer initiation, progression, and its application in therapy
Liang, C., Zhou, Z., Li, P., & Xiao, H. (2025) · International Journal of Cancer · doi:10.1002/ijc.70063 · Cited by 1
Strategies for engineering domesticated and undomesticated human microbes
Liu, D., Hsieh, M.-L., & Ding, Y. (2025) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2025.103368 · Cited by 3
Immuno-oncology approaches to overcome T cell exhaustion in melanoma
El-Sehrawy, A. A. M. A., Alshahrani, M. Y., Fedwi, M. M., Ganesan, S., Al-Khafaji, Z., Arora, V., Pal, A., Nayak, P. P., Islomov, S., & Hsu, C. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152454 · Cited by 2
In vitro platforms for reconstructing skin–microbiome interactions
Park, J., Kim, J., Cho, S., & Shin, W. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.02.006 · Cited by 1
The ecological dynamics of skin microbiota in skin health and diseases
Pu, P., Wang, Y., Liu, X., Pang, Y., Qiang, L., & Wang, W. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00305-25 · Cited by 2
Liu, H., Shang, H., Chen, H., Zhou, C., Luo, B., Zhao, D., Xiao, Z., Cui, Y., Zhang, Y., & Xie, R. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.03.023 · Cited by 1
RetractedApplying microbial ecology frameworks to microbial therapies for wildlife
Bornbusch, S. L., & Muletz‐Wolz, C. R. (2026) · mSystems · doi:10.1128/msystems.00598-25 · Cited by 1
Xie, T., Hao, Y., & Li, Q. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128577 · Cited by 1
Progress in engineered bacterial cancer therapies
Pico-Sánchez, E., & Fernández, L. Á. (2026) · Current Opinion in Microbiology · doi:10.1016/j.mib.2026.102785 · Cited by 2
Skin microbiome and cutaneous aging mechanisms and clinical implications
Bautista, J., Iñiguez-Ramírez, A., Chávez, J. A. V., Larco, D. S. B., & López-Cortés, A. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1917816 · Cited by 1
Cracking cancer with engineered skin commensals
Galié, S., & Nezi, L. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.05.023 · Cited by 1
A genetic toolbox for engineering C. acnes
Chen, Y. E. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101199 · Cited by 1
Self-citationDétournement d’une bactérie commensale pour la vaccination anti-tumorale
Mabrouk, N., Méjean, F., Tanchot, C., & Tartour, É. (2023) · médecine/sciences · doi:10.1051/medsci/2023115
An emerging and promising anticancer strategy: colonization of engineered Staphylococcus epidermidis
Liu, Y., & Cai, Y. (2024) · MedComm · doi:10.1002/mco2.467
Virazels, M. (2023) · theses.fr (ABES) · doi:10.70675/1ffc7bb5z666fz49d3zb5b9z81ce3e4d33d5
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_6
Unveiling the hidden causal links: skin flora and cutaneous melanoma
Zhang, Z., Wu, W., Lin, J., & Li, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1451175 · Cited by 2
Lin, Y., Wang, C., You, H., Fang, M., Li, J., Huang, S., Xu, C., & Wang, L. (2025) · Digestion · doi:10.1159/000545005
The vaccine we all wear: Skin microbiota can be engineered into topical vaccines
Bousbaine, D. (2025) · Science · doi:10.1126/science.adz0485
Self-citationZhao, Y., Liu, X., Song, P., Chen, Q., Yang, X., & Yu, W. (2025) · Current Microbiology · doi:10.1007/s00284-025-04390-z
Zhao, R., Li, Y., Han, M., Zhang, Y., Lin, S., Yu, M., Li, D., Zhang, B., Peng, L., & Che, Y. (2025) · Medicine · doi:10.1097/md.0000000000043571 · Cited by 1
Host Immune Mechanisms towards commensal Staphylococcus epidermidis in Cream VaccinesPreprint
Tran, L. N. K. (2025) · doi:10.22541/au.175571735.54156731/v1
Andersson, T., Anwaar, S., Fuentes-Lemus, E., Allhorn, M., Happonen, L., Veitch, M., Chew, H. Y., de, M. M., Tanner, L., Brüggemann, H., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.08.038
The canine T cell receptor repertoire
Allaway, D., Harrison, M. T., Pink, C., Haydock, R., Jayaprakash, A. D., & Sachidanandam, R. (2025) · ImmunoHorizons · doi:10.1093/immhor/vlaf040
Wang, M., Wang, H., Wang, Y., Gao, C., Fan, L., Li, J., & Zhu, Q. (2025) · Biomedicines · doi:10.3390/biomedicines13112805
Gu, Z., Gao, H., Gao, H., Fan, Z., Zhang, W., Xing, D., Zhou, X., Yu, H., Zhao, T., Wu, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-78356-5
Ou, Z., Li, Q., Pan, B., Feng, J., He, X., Wu, Y., Wang, Y., Cai, Z., Lin, J., & Zheng, L. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174433
Bacterial colonized melanoma skin models allow to study host–microbe interactions in situ
Rosin, A., Krause, J. L., Sprenger, H., Kissner, M. S., Neuhaus, K., Tralau, T., Höper, T., & Lemoine, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1736700
mGem: Applying microbiome therapeutic learnings to next-generation agricultural bioproducts
Holmes, E. C. (2026) · mBio · doi:10.1128/mbio.03323-25
A decade of research in review
Despang, A., Bishop, A., Doerr, A., Li, R., Cheifet, B., & Aschheim, K. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03030-6
Bioengineering and synthetic biology in skin care
Alnator, A. A., & Nazir, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41640-8.00012-x
Current therapeutic interventions for immune dysregulation induced by gut microbiota
Khatami, F., Karimian, S., & Mohammadipanah, F. (2026) · European journal of medical research · doi:10.1186/s40001-026-04579-3
Su, X., Xiang, Y., Zhao, H., Li, O., Zhang, L., & Guo, B. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1839030 · Cited by 1
Abo, H., Kim, S.-E. G., Ngo, V. L., Kuczma, M., & Gewirtz, A. T. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.100382
PSMε controls skin commensal CD8 + T cell activationPreprint
Owens, W. S., Lenzi, K., Geng, W., Hurd, A., Liu, J., Staudinger, C., Berdy, B. M., Lian, C. G., Udeshi, N. D., Carr, S. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.30.741773
Self-citationArming the living drugs: nanoengineered bacteria for precision tumor theranostics
Yu, Y., Yang, W., & Zhang, B. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04888-z
Jalal, M. E., Hamidi, R., Harris, B., Elmaghraby, A. S., Friedland, R. P., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261478312
Bhowmick, S., Ramos‐León, F., Ramamurthi, K. S., & Dickey, S. W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.26.747279
Gut-to-Tumor Translocation of Bifidobacterium longum Potentiates Radio-Immunotherapy
Yu, J., Xu, P., Qiu, L., Gu, Y., Wang, Y., Zhang, L. W., Qin, S., & Wang, Y. (2026) · Fundamental Research · doi:10.1016/j.fmre.2026.08.012
The immune signature of dermatological malignancies and its therapeutic implications
Ashinze, P., Chime, N., & Ayanleke, E. (2026) · Forum Dermatologicum · doi:10.5603/fd.113645
The emerging role of microbiota in neuro-oncology
Morad, G., Soto, R. A., Ajami, N. J., Ferguson, S. D., & Wargo, J. A. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01266-z
Approaches and gaps in skin microbiome engineering
Rentz, L. E., Sathe, M., & Karig, D. (2026) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen8511
Enzymatic attachment of antigens to probe immune modulation by skin commensalsPreprint
Bousbaine, D., Lalgudi, P. V., Bauman, K. D., Tsang, E., Nguyen, T. T. D., James, A., Chiang, M. L., Zhao, A., Terasaki, M., Swenson, J. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.31.763323
Self-citationHan, J., Kashentseva, E. A., Dmitriev, I. P., Lu, Z. H., Goedegebuure, S. P., Li, L., Gillanders, W. E., & Curiel, D. T. (2026) · ACS Nano · doi:10.1021/acsnano.6c03263
Metadata
- Authors
- Chen, Y. E., Bousbaine, D., Veinbachs, A., Atabakhsh, K., Dimas, A., Yu, V. K., Zhao, A., Enright, N. J., Nagashima, K., Belkaid, Y., & Fischbach, M. A.
- Affiliations
- San Francisco VA Medical Center (US)
- Stanford Medicine (US)
- National Institutes of Health (US)
- Corresponding author
- Fischbach, Michael A.
- ORCID
- Venue
- Science
- Published
- 2023-04-14
- Volume
- 380
- Issue
- 6641
- Pages
- 203-210
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC12356174
- OpenAlex
- W4365457270
- Cited by
- 191
- References
- 68
- Citations by year
- 2026: 40 · 2025: 80 · 2024: 48 · 2023: 23
- FWCI
- 20.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- Howard Hughes Medical Institute
- Leona M. and Harry B. Helmsley Charitable Trust
- Harvard University
- Children's Discovery Institute (CDI-CORE-2019-813, CDI-CORE-2015-505)
- Open Philanthropy Project
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- National Institutes of Health (DK110174)
- Washington University School of Medicine in St. Louis (CDI-CORE-2015-505, CDI-CORE-2019-813)
- Center for Cellular Imaging, Washington University
- National Cancer Institute (P30CA124435)
- National Institute of Allergy and Infectious Diseases (ZIAAI001115, ZIAAI001132)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK110174)
- NHLBI Division of Intramural Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- Staphylococcus epidermidis, melanoma, antitumor T-cell responses, tumor-specific T cells, skin colonization, T cell cytotoxicity, metastatic melanoma, cancer immunotherapy
- MeSH terms
- Antigens, Neoplasm, Genetic Engineering, Humans, Immunity, Cellular, Melanoma, Skin, Skin Neoplasms, Staphylococcus epidermidis, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.